Literature DB >> 6500147

Maternal blood pressure response to the intravenous administration of pethidine-promethazine during labor.

M Ron, M Menashe, D Hochner-Celnikier, Z Palti.   

Abstract

A double blind study on the effect of an intravenous injection of a combination of 75 mg pethidine and 25 mg promethazine was conducted on 200 women during normal deliveries. Four groups of 50 women each received injections of pethidine and promethazine, promethazine alone, pethidine alone and normal saline. In the pethidine-promethazine group there was a significant elevation in blood pressure in the first 10 min following the injection as compared with the other groups. The mean (+/- S.D.) systolic blood pressure after the injection was 143.2 +/- 14.3 mmHg as compared with 118.9 +/- 8.4 mmHg before the injection, and the mean diastolic blood pressure as 96.9 +/- 8.4 mmHg after the injection as compared with 77.7 +/- 9.3 mmHg before the injection. 25 mg promethazine alone caused slight elevation in blood pressure which was further increased by combination with pethidine. The clinical significance of these observations is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500147     DOI: 10.1016/0028-2243(84)90029-7

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

Review 1.  Parenteral opioids for maternal pain relief in labour.

Authors:  Roz Ullman; Lesley A Smith; Ethel Burns; Rintaro Mori; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

2.  Development and validation of a sensitive LC-MS method for the determination of promethazine hydrochloride in human plasma and urine.

Authors:  Ping Liu; Sun Liang; Ben-Jie Wang; Rui-Chen Guo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jul-Sep       Impact factor: 2.569

Review 3.  Parenteral opioids for maternal pain management in labour.

Authors:  Lesley A Smith; Ethel Burns; Anna Cuthbert
Journal:  Cochrane Database Syst Rev       Date:  2018-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.